U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911632) titled 'Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension' on March 28.

Brief Summary: MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Interstitial Lung Disease (ILD)

Intervention: DEVICE: ECG-based AI Device - Results Returned to Investiga...